Introduction
Retatrutide is one of the newest tri-agonist peptides, acting on GLP-1, GIP, and glucagon receptors. This multi-pathway action is attracting attention in cutting-edge labs.

Research Trends

• Studies into multi-agonist signaling.

• Investigations into receptor network effects.

• Exploration of tri-agonists for broader biochemical modeling.

Why It Matters
Tri-agonists mark an exciting evolution, offering more versatile tools for researchers studying metabolic pathways.

Polygon Peptides Advantage
Every vial of retatrutide is tested for consistency and supplied with COA documentation for transparency.